SCHEMBL2937866

SCHEMBL2937866

Cc1nn(-c2ccccc2)c(C)c1C(=O)Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.64
MAPT P10636 3/20 0.64
NPSR1 Q6W5P4 1/20 0.64
PDE4D Q08499 1/20 0.64
NPC1 O15118 5/20 0.59
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
POLB P06746 3/20 0.55
KDM4E B2RXH2 1/20 0.55
APEX1 P27695 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.55
HTT P42858 1/20 0.55
WNT3A P56704 1/20 0.54
HPGD P15428 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2938583 0.86 MEN1 (0.69) RAB9AMAPTNPSR1PDE4DNPC1
SCHEMBL4130422 0.85 RAB9A (0.66) RAB9AMAPTNPSR1PDE4DNPC1
SCHEMBL14097171 0.84 HPGD (0.69) RAB9AMAPTNPSR1PDE4DNPC1
SCHEMBL28524227 0.83 RAB9A (0.64) RAB9AMAPTNPSR1PDE4DNPC1
SCHEMBL6267877 0.83 MEN1 (0.78) RAB9AMAPTNPSR1PDE4DNPC1
SCHEMBL8031114 0.81 RAB9A (0.61) RAB9AMAPTNPSR1PDE4DNPC1
SCHEMBL15153224 0.81 RAB9A (0.74) RAB9AMAPTNPSR1PDE4DNPC1
SCHEMBL4233402 0.80 SLC34A1 (0.54) RAB9AMAPTNPSR1PDE4DNPC1
SCHEMBL11250407 0.78 ALOX15 (0.58) RAB9AMAPTNPSR1PDE4DNPC1
Hydrochloric Acid SCHEMBL28546374 0.78 RAB9A (0.66) RAB9AMAPTNPSR1PDE4DNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682549-B1 IMIDAZO[1,2-A]PYRIDINE ANXIOLYTICS SEPRACOR INC (US) 2010-09-22 EP disclosed
US-7723324-B2 Imidazo[1,2-A]pyridine anxiolytics SEPRACOR, INC. (US) 2010-05-25 US disclosed
US-7566725-B2 Imidazo[1,2-A] pyridine anxiolytics SEPRACOR INC. (US) 2009-07-28 US disclosed
US-20080096867-A1 Imidazo[1,2-A] Pyridine Anxiolytics SEPRACOR INC. (US) 2008-04-24 US disclosed
US-20070043074-A1 IMIDAZO[1,2-A] PYRIDINE ANXIOLYTICS SEPRACOR INC. (US) 2007-02-22 US disclosed
US-7148353-B2 Imidazo[1,2-a] pyridine anxiolytics SEPRACOR INC. (US) 2006-12-12 US disclosed
EP-1682549-A2 IMIDAZO[1,2-A]PYRIDINE ANXIOLYTICS Sepracor Inc. (US) 2006-07-26 EP disclosed
US-20050171144-A1 Imidazo[1,2-a] pyridine anxiolytics SEPRACOR INC. (US) 2005-08-04 US disclosed
WO-2005044818-A2 IMIDAZO[1,2-A]PYRIDINE ANXIOLYTICS SEPRACOR, INC. (US) 2005-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043074-A1 IMIDAZO[1,2-A] PYRIDINE ANXIOLYTICS CNR1, CNR2, GABRA5 RAB9A 2233/4885MAPT 1056/4885NPSR1 28/4885
US-20050171144-A1 Imidazo[1,2-a] pyridine anxiolytics CNR1, CNR2, GABRA5 RAB9A 2233/4885MAPT 1056/4885NPSR1 28/4885
US-20080096867-A1 Imidazo[1,2-A] Pyridine Anxiolytics MTNR1B, ADORA2B, ADRA2B RAB9A 995/4885MAPT 1930/4885NPSR1 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.